According to the recent research report titled ‘Influenza Diagnostic Tests Market Size By Influenza Type, By Test Type, By Patient (Pediatric {0 to 4 years, 5 to 17 years}, Adult {18 to 49 years, 50 to 64 years, 65+ years}), By End-use (Hospitals, Diagnostics Centers, Research Laboratories) Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025, available with Market Study Report, global influenza diagnostic tests market expected to record a substantial growth during 2021-2026, amassing more than USD 1.5 billion by the end of the forecast period.
 

Rising cognizance regarding availability of various diagnostic tests and disease management along with growing R&D activities are stimulating global influenza diagnostic tests market growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2212520/
 

Increasing global prevalence of influenza and associated chronic diseases are also enhancing the overall market outlook. According to the Centers for Disease Control and Prevention (CDC), influenza kills between 12,000 and 79,000 people in the United States each year.
 

Despite the promising trajectory of worldwide influenza diagnostics tests industry, strict approval process for new diagnostic test coupled with concerns over some differences in sensitivity and specificity of the tests are hindering the business expansion.
 

With respect to influenza type, the type A Flu segment is anticipated to exhibit 7.0% CAGR owing to rising influenza cases worldwide.
 

Elaborating on test type, the traditional diagnostic method segment of global influenza diagnostic tests market was worth USD 594.8 million in 2018. Traditional diagnostic tests are becoming highly popular as a result of the rapid development of relevant tests to diagnose influenza antigens quickly and show reliable results in a qualitative format.
 

Meanwhile, rapid influenza diagnostic test segment is predicted to rise significantly over the coming years. These are antigen detection assays that can detect influenza in minimal time with high precision and specificity.
 

Based on patient type, influenza diagnostic tests in children are expected to develop at a rate of 7.7%, owing to rising prevalence of influenza in children.
 

As per end use scope, hospitals segment amassed USD 278.3 million in 2018 and is projected to grow substantially creditable to patients' preference for diagnostics in hospitals in developed countries, due to increased understanding of early disease detection.
 

Regionally, the U.S. influenza diagnostic tests market is expected to record 6.3% by 2027, owing to high presence of qualified practitioners, availability of well-developed healthcare infrastructure, and technological advancements, as well as the rising influenza prevalence across the country.

 

Meanwhile, China influenza diagnostic tests industry was remunerated at USD 70.4 million, owing to increasing influenza prevalence as well as rising number of government initiatives to spread awareness about influenza diagnostics and treatment.

Key players impacting global influenza diagnostic tests market trends are Integra LifeSciences Holdings Corporation, Arthrex, Stryker Corporation, Extremity Medical, Zimmer Biomet Holdings, Smith & Nephew plc, Acumed LLC., Wright Medical Technology, and Tornier N.V.